Neurofibromatosis 1

This is a genetic condition that causes tumors to grow on nerves. It's often called NF1. People with NF1 may have skin changes like cafe-au-lait spots and may develop tumors on their nerves. It can also affect the eyes, bones, and learning.

Condition

What people with Neurofibromatosis 1 report

Every report comes from a Lived member, sent anonymously.

Have you tried Gomekli (Mirdametinib) for Neurofibromatosis 1?

NameHow it went

About Neurofibromatosis 1

What It Is

Neurofibromatosis type 1 (NF1) is a genetic condition that affects the skin and the nervous system. Its most recognizable signs are café-au-lait spots, flat patches that are darker than the surrounding skin, and neurofibromas, soft tumors that grow along nerves. Neurofibromas are usually noncancerous, but depending on their size and location they can cause pain, visible changes in appearance or pressure on nearby structures. NF1 varies a great deal from person to person. Some people have little beyond the skin findings, while others develop larger tumors, learning difficulties, bone changes or problems with vision. The spots usually appear in early childhood, freckling in the armpits or groin tends to follow by about age 5, and most neurofibromas on or under the skin appear in the teenage years or later. NF1 affects roughly 1 in 3,000 people and is the most common form of neurofibromatosis. It is a different condition from NF2-related schwannomatosis, which mainly causes tumors on the nerves for hearing and balance.

Causes & Risk Factors

NF1 is caused by a change in the NF1 gene. This gene normally makes a protein called neurofibromin, which acts as a brake on cell growth. When the brake is missing, cells that surround nerves can grow into tumors. Researchers do not yet fully understand how the same gene change also leads to the skin spots, learning differences and other features. About half of people with NF1 inherit it from a parent. The other half are the first in their family to have it, because the gene change arose new. Either way, a person with NF1 has a 50% chance of passing it to each of their children. The gene change is present from birth; NF1 is not something a person develops later because of an exposure or habit. Which features a person will develop, and how severe they will be, cannot currently be predicted.

How It's Diagnosed

Most people are diagnosed in childhood from what a clinician sees on examination. Under international criteria revised in 2021, NF1 is diagnosed when a person without an affected parent has two or more of these features: six or more café-au-lait spots (larger than 5 millimeters across before puberty, or 15 millimeters after), freckling in the armpits or groin, two or more neurofibromas or one plexiform neurofibroma (a larger tumor that grows along several branches of a nerve), a tumor of the optic pathway (the nerves connecting the eyes to the brain), small harmless bumps on the colored part of the eye called Lisch nodules or related changes at the back of the eye, a characteristic bone change such as bowing of the shin bone, or an NF1 gene change found on genetic testing. A child of a parent with NF1 needs only one of these. Because features appear over years, a young child with only a few spots may be watched for a while before the diagnosis is clear. Spots and freckling alone most likely mean NF1, but a milder condition called Legius syndrome can look the same, and genetic testing can tell them apart. Testing also helps when the picture is unclear or for family planning, though many people are diagnosed without it. A detailed eye exam is part of the assessment. Brain MRI is generally done when symptoms or eye findings suggest a tumor, not as routine screening in a child who is well.

Treatment Options

There is no cure for NF1, so care centers on watching for complications and treating specific problems as they arise. Many people never need long treatment for any single feature. What nearly everyone needs is regular follow-up with a clinician or specialty clinic experienced in NF1. Neurofibromas on or under the skin can be removed surgically when they hurt, catch on clothing or affect appearance, although new ones may keep appearing. Plexiform neurofibromas are harder to remove because they wrap around nerves and nearby tissue. For those that cause problems such as pain, disfigurement or loss of function and cannot be fully removed, two daily oral medicines are FDA approved: selumetinib (Koselugo), for adults and children 1 year and older, and mirdametinib (Gomekli), for adults and children 2 years and older. Both are MEK inhibitors, targeted drugs that block a growth signal inside the tumor cells. In the main trial in children, roughly half to two thirds of the treated tumors shrank by at least 20%, depending on how the scans were reviewed; tumors rarely disappear completely. The medicines are taken for as long as they help and are tolerated, often cause rash and diarrhea, need regular heart and eye checks, and can harm a developing pregnancy. Other problems are treated as they come up. An optic pathway tumor that threatens vision is usually treated with chemotherapy, and radiation is avoided where possible for the low-grade brain tumors seen in NF1. Scoliosis may be managed with bracing or surgery. Cancers that develop are treated with surgery, chemotherapy or radiation. For children, a formal neuropsychological assessment can pin down learning or attention difficulties and guide an individualized plan at school.

What to Expect

NF1 is lifelong and its course is hard to predict. Most children with NF1 grow and develop within the normal range, and some people go through life with relatively few medical problems. Others carry a heavier load of tumors, pain or learning challenges. New neurofibromas tend to appear through adolescence and adulthood, and they often become more numerous with age. Regular checkups are the backbone of care, because several complications cause no symptoms early on. A European expert guideline suggests review by an NF1-experienced clinician at least yearly until age 10, at least every two years for older children and at least every three years for adults. Visits focus on a history and physical exam looking for new or changing tumors, along with development, learning and wellbeing. Young children also need eye exams at least yearly until about age 8, since optic pathway tumors are most common between ages 1 and 6 and often affect vision only later. High blood pressure in someone with NF1 deserves a search for an underlying cause, such as a narrowed artery to the kidney or a rare adrenal tumor called a pheochromocytoma. NF1 raises the lifetime risk of some cancers. The most important is a malignant peripheral nerve sheath tumor, a cancer that can arise from a neurofibroma, usually in adolescence or adulthood. Women with NF1 also have a higher risk of breast cancer before age 50, and the same guideline advises starting screening at 30, preferably with a yearly breast MRI. Learning and attention difficulties affect more than half of people with NF1, and chronic pain, fatigue and the strain of visible tumors or worry about cancer can weigh on daily life. Psychological support, school services and NF patient organizations can help as needs change.

When to Seek Help

Arrange an evaluation if a child has six or more café-au-lait spots, freckling in the armpits or groin, or a parent with NF1. Once NF1 is diagnosed, ask for referral to a clinic experienced in the condition, and raise new learning or behavior problems, raised blood pressure readings or a curving spine at a routine visit. Contact the care team promptly if a neurofibroma becomes painful, grows quickly, or turns harder or changes in feel, since these changes need imaging to check for cancer. Prompt assessment is also needed for new vision problems or a bulging eye, new or changing seizures, an unusual or worsening headache, or new weakness or numbness.

Questions to Ask Your Doctor

  1. 1.Which features of NF1 are present now, and what should we be watching for at this age?
  2. 2.Would genetic testing add anything in our situation, including for family planning?
  3. 3.How often should we have eye exams, imaging or other checks, and who will coordinate them?
  4. 4.If a plexiform neurofibroma causes problems, how would we weigh surgery against a medicine such as selumetinib or mirdametinib?
  5. 5.What school, psychological or pain support can an NF clinic connect us with?

Last reviewed • Oct 2026

Educational content, not medical advice.